Cargando…
A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma
Clinical non-functioning pituitary adenoma (NFPA) accounts for >30% of all pituitary adenomas, and the recurrence rate is notably high. The ability to predict tumour recurrence during initial surgery will aid in determining if adjunctive therapy is required to reduce recurrence. With the aim of d...
Autores principales: | Guo, Jing, Wang, Zhuang, Miao, Yazhou, Shen, Yutao, Li, Mingxuan, Gong, Lei, Wang, Hongyun, He, Yue, Gao, Hua, Liu, Qian, Li, Chuzhong, Zhang, Yazhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278571/ https://www.ncbi.nlm.nih.gov/pubmed/30542712 http://dx.doi.org/10.3892/or.2018.6851 |
Ejemplares similares
-
The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019) -
Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020) -
A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021) -
Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
por: Cheng, Sen, et al.
Publicado: (2019) -
Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma
por: Cheng, Sen, et al.
Publicado: (2020)